Publicaciones en las que colabora con JOSE ANTONIO FERRAGUT RODRIGUEZ (35)

2006

  1. Structural and functional changes induced in the nicotinic acetylcholine receptor by membrane phospholipids

    Journal of Molecular Neuroscience

2003

  1. Susceptibility of multidrug resistance tumor cells to apoptosis induction by histone deacetylase inhibitors

    International Journal of Cancer, Vol. 104, Núm. 5, pp. 579-586

2002

  1. Protein orientation affects the efficiency of functional protein transplantation into the Xenopus oocyte membrane

    Journal of Membrane Biology, Vol. 185, Núm. 2, pp. 117-127

1998

  1. Altered drug membrane permeability in a multidrug-resistant Leishmania tropica line

    Biochemical Pharmacology, Vol. 55, Núm. 2, pp. 131-139

  2. Inactivating peptide of the Shaker B potassium channel: Conformational preferences inferred from studies on simple model systems

    Biochemical Journal, Vol. 331, Núm. 2, pp. 497-504

  3. Structural stabilization of botulinum neurotoxins by tyrosine phosphorylation

    FEBS Letters, Vol. 429, Núm. 1, pp. 78-82

1997

  1. Effects of pH on the kinetics of the interaction between anthracyclines and lipid bilayers

    European Biophysics Journal, Vol. 26, Núm. 6, pp. 427-431

  2. Functional incorporation of P-glycoprotein into Xenopus oocyte plasma membrane fails to elicit a swelling-evoked conductance

    Biochemical and Biophysical Research Communications, Vol. 237, Núm. 2, pp. 407-412

1996

  1. Interaction between ion channel-inactivating peptides and anionic phospholipid vesicles as model targets

    Biophysical Journal, Vol. 71, Núm. 3, pp. 1313-1323

1995

  1. Adoption of beta structure by the inactivating "ball" peptide of the Shaker B potassium channel

    Biophysical Journal, Vol. 68, Núm. 3, pp. 858-865

  2. Incorporation of reconstituted acetylcholine receptors from Torpedo into the Xenopus oocyte membrane

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 92, Núm. 18, pp. 8468-8472

1994

  1. A Role for Cholesterol as a Structural Effector of the Nicotinic Acetylcholine Receptor

    Biochemistry, Vol. 33, Núm. 13, pp. 4065-4071

  2. Role of cholesterol as a structural and functional effector of the nicotinic acetylcholine receptor

    Biochemical Society Transactions

1993

  1. Labeling of the nicotinic acetylcholine receptor by a photoactivatable steroid probe: effects of cholesterol and cholinergic ligands

    BBA - Biomembranes, Vol. 1149, Núm. 1, pp. 135-144

  2. Possible coexistence of two independent mechanisms contributing to anthracycline resistance in leukaemia P388 cells

    European Journal of Cancer, Vol. 29, Núm. 15, pp. 2144-2150

1992

  1. Different distribution of daunomycin in plasma membranes from drug-sensitive and drug-resistant P388 leukemia cells

    BBA - Biomembranes, Vol. 1104, Núm. 1, pp. 111-116

  2. Protein stability and interaction of the nicotinic acetylcholine receptor with cholinergic ligands studied by Fourier-transform infrared spectroscopy

    Biochemical Journal, Vol. 288, Núm. 2, pp. 421-426

  3. Protein structural effects of agonist binding to the nicotinic acetylcholine receptor

    FEBS Letters, Vol. 314, Núm. 2, pp. 171-175

  4. Rapid kinetics of the interaction between daunomycin and drug-sensitive or drug-resistant P388 leukemia cells

    FEBS Letters, Vol. 301, Núm. 1, pp. 119-123

  5. Verapamil reverses the ultrastructural alterations in the plasma membrane induced by drug resistance

    FEBS Letters, Vol. 314, Núm. 3, pp. 404-408